Short answer
Perspective Therapeutics, Inc. (CATX) filed an 8-K current report with the SEC on May 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Preliminary March 31, 2026 cash, cash equivalents and short-term investments disclosed in analyst presentation.
Perspective Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Preliminary March 31, 2026 cash, cash equivalents and short-term investments disclosed in analyst presentation
- Financial data unaudited and not reviewed by WithumSmith+Brown, PC
- Actual quarterly results may change after closing procedures, final adjustments and other developments
- Presentation also covers clinical programs, manufacturing technologies and infrastructure
Item 8.01 · Other Events
- 8-K Item 8.01 includes Exhibit 99.1, a company presentation
- Presentation may contain investor-relevant updates, but substantive content is not included in the provided filing text
- Filing signed May 4, 2026 by CFO Joel Sendek
Item EX-99.1 · Exhibit EX-99.1
- Investor presentation centers on ²¹²Pb radiopharmaceutical platform, proprietary chelation, theranostics, and regional manufacturing
- VMT-α-NET Phase 1/2a program targets SSTR2-positive neuroendocrine tumors, with potential registration study at current dose
- AACR 2026 analysis includes 64 treated patients and highlights durable disease control across doses
- Pipeline expansion includes meningioma, CCK2R-positive tumors, medullary thyroid cancer, and FAP-targeted programs
- Integrated ²¹²Pb isotope production and ready-to-administer regional delivery aim to reduce supply constraints and support commercial scaling
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Perspective Therapeutics, Inc. 8-K filings
Get the next CATX 8-K as it lands
Follow CATX for push alerts, or ask the research agent what this filing means.